American Journal of Ophthalmology
Volume 140, Issue 1 , Pages 16-22 , July 2005

Perioperative Complications of Trabeculectomy in the Collaborative Initial Glaucoma Treatment Study (CIGTS)

  • Henry D. Jampel, MD, MHS

      Affiliations

    • Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, Maryland
    • Corresponding Author InformationInquiries to Henry D. Jampel, MD, MHS, Johns Hopkins Hospital, Wilmer Ophthalmological Institute, Maumenee B-110, 600 North Wolfe Street, Baltimore, MD 21287-9205; fax: (410) 502-7493
  • ,
  • David C. Musch, PhD, MPH

      Affiliations

    • Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, Michigan
    • Department of Epidemiology, University of Michigan, Ann Arbor, Michigan
  • ,
  • Brenda W. Gillespie, PhD

      Affiliations

    • Department of Biostatistics, University of Michigan, Ann Arbor, Michigan
  • ,
  • Paul R. Lichter, MD

      Affiliations

    • Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, Michigan
  • ,
  • Martha M. Wright, MD

      Affiliations

    • Department of Ophthalmology, University of Minnesota, Minneapolis, Minnesota.
  • ,
  • Kenneth E. Guire, MS

      Affiliations

    • Department of Biostatistics, University of Michigan, Ann Arbor, Michigan
  • ,
  • Collaborative Initial Glaucoma Treatment Study Group

,Accepted 1 February 2005.

References 

  1. Musch DC , Lichter PR , Guire KE , Standardi CL . The Collaborative Initial Glaucoma Treatment Study (study design, methods, and baseline characteristics of enrolled patients) . Ophthalmology . 1999;106:653–662
  2. Janz NK , Wren PA , Lichter PR , Musch DC , Gillespie BW , Guire KE . Quality of life in newly diagnosed glaucoma patients (the Collaborative Initial Glaucoma Treatment Study) . Ophthalmology . 2001;108:887–897
  3. Lichter PR , Musch DC , Gillespie BW , et al.   Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery . Ophthalmology . 2001;108:1943–1953
  4. Migdal C , Gregory W , Hitchings R . Long-term functional outcome after early surgery compared with laser and medicine in open-angle glaucoma . Ophthalmology . 1994;101:1651–1656
  5. Jay JL , Allan D . The benefit of early trabeculectomy versus conventional management in primary open angle glaucoma relative to severity of disease . Eye . 1989;3:528–535
  6. Jay JL , Murray SB . Early trabeculectomy versus conventional management in primary open angle glaucoma . Br J Ophthalmol . 1988;72:881–889
  7. Jay JL . Earlier trabeculectomy . Trans Ophthalmol Soc U.K. . 1983;103:35–38
  8. Ederer F, Gaasterland DA, Dally LG, Kim J, Van Veldhuisen PC, Blackwell B, et al. 11. Risk factors for failure of trabeculectomy and argon laser trabeculoplasty . Am J Ophthalmol . 2002;134:481–498
  9. Watson PG , Jakeman C , Ozturk M , Barnett MF , Barnett F , Khaw KT . The complications of trabeculectomy (a 20-year follow-up) . Eye . 1990;4:425–438
  10. Song MS , Shin DH , Spoor TC . Incidence of ptosis following trabeculectomy (a comparative study) . Korean J Ophthalmol . 1996;10:97–103
  11. Kaplan LJ , Jaffe NS , Clayman HM . Ptosis and cataract surgery. A multivariate computer analysis of a prospective study . Opthalmology . 1985;92:237–242
  12. Zacharia PT , Deppermann SR , Schuman JS . Ocular hypotony after trabeculectomy with mitomycin C . Am J Ophthalmol . 1993;116:314–326
  13. Scott IU , Greenfield DS , Schiffman J , et al.   Outcomes of primary trabeculectomy with the use of adjunctive mitomycin . Arch Ophthalmol . 1998;116:286–291
  14. Hylton C , Congdon N , Friedman D , et al.   Cataract after glaucoma filtration surgery . Am J Ophthalmol . 2003;135:231–232
  15. DeBry PW , Perkins TW , Heatley G , Kaufman P , Brumback LC . Incidence of late-onset bleb-related complications following trabeculectomy with mitomycin . Arch Ophthalmol . 2002;120:297–300

 Members of the CIGTS Study Group are listed in the Appendix to Musch DC et al. Ophthalmology 1999;106:653–662.Dr. Jampel is the recipient of a Research to Prevent Blindness Physician-Scientist Award.Supported by National Institutes of Health, Bethesda, Maryland, grants EY09100, EY09140, EY09141, EY09142, EY09143, EY09144, EY09145, EY09148, EY09149, EY09150, and EY09639.

PII: S0002-9394(05)00149-2

doi: 10.1016/j.ajo.2005.02.013

American Journal of Ophthalmology
Volume 140, Issue 1 , Pages 16-22 , July 2005